Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost
Arindam Halder, Ajay J Khopade Formulation Department, Sun Pharmaceutical Industries, Ltd, Tandalja, Vadodara, IndiaCorrespondence: Ajay J KhopadeSun Pharmaceutical Industries, Ltd., Tandalja, Vadodara 390020, Gujarat, IndiaTel +91 22 6645 5645 Ext 1900Email ajay.khopade@sunpharma.comPurpose: Prosta...
Guardado en:
Autores principales: | Halder A, Khopade AJ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af7294b0dee04c9cb30ddfa2ca1659bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost
por: García-Feijoo J, et al.
Publicado: (2016) -
Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
por: Beck DER, et al.
Publicado: (2017) -
Influence of EDTA and its Association with Benzalkonium Chloride on Enterococcus faecalis Adhesion to Dentin
por: Titato,Pedro Cesar Gomes, et al.
Publicado: (2020) -
Detection of qacEΔ1, qacG, qacE, qacF resistance genes in Escherichia coli producing broad-spectrum beta-lactamases to benzalkonium chloride
por: F Hadadi, et al.
Publicado: (2019) -
Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
por: Mylla Boso AL, et al.
Publicado: (2020)